Evidence map›Paper›PMID 32280579›Full record

ArticleBeilstein journal of nanotechnology2020

Identification of physicochemical properties that modulate nanoparticle aggregation in blood.

Ludovica Soddu, Duong N Trinh, Eimear Dunne, Dermot Kenny, Giorgia Bernardini, Ida Kokalari, Arianna Marucco, Marco P Monopoli, Ivana Fenoglio

Open access · diamondAbstract read
In one paragraph

Article in Beilstein journal of nanotechnology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.1field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Optimizing Sunscreen Safety: The Impact of TiONanomaterials (Basel, Switzerland) · 2025
    Article
  5. Review
  6. Review
  7. Article
  8. Effect of spParticle and fibre toxicology · 2023
    Article
  9. Article
  10. Review
  11. Article
  12. Inhibitory Effect againstFoods (Basel, Switzerland) · 2022
    Article
  13. Article
  14. Ethyl Hydroxyethyl Cellulose-A Biocompatible Polymer Carrier in Blood.International journal of molecular sciences · 2022
    Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Ludovica SodduDepartment of Chemistry, University of Torino, 10125 Torino, Italy.ORCID https://orcid.org/0000-0001-6675-2318
Duong N TrinhDepartment of Chemistry, Royal College of Surgeons in Ireland (RCSI), 123 St Stephen Green, Dublin 2, Ireland.
Eimear DunneMolecular and Cellular Therapeutics, Royal College of Surgeons in Ireland (RCSI), 123 St Stephen Green, Dublin 2, Ireland.
Dermot KennyMolecular and Cellular Therapeutics, Royal College of Surgeons in Ireland (RCSI), 123 St Stephen Green, Dublin 2, Ireland.ORCID https://orcid.org/0000-0001-5548-3263
Giorgia BernardiniDepartment of Chemistry, University of Torino, 10125 Torino, Italy.ORCID https://orcid.org/0000-0002-2752-8230
Ida KokalariDepartment of Chemistry, University of Torino, 10125 Torino, Italy.ORCID https://orcid.org/0000-0003-0859-1354
Arianna MaruccoDepartment of Chemistry, University of Torino, 10125 Torino, Italy.
Marco P MonopoliDepartment of Chemistry, Royal College of Surgeons in Ireland (RCSI), 123 St Stephen Green, Dublin 2, Ireland.ORCID https://orcid.org/0000-0002-2035-6894
Ivana FenoglioDepartment of Chemistry, University of Torino, 10125 Torino, Italy.ORCID https://orcid.org/0000-0002-6946-3105
Royal College of Surgeons in Ireland · IEUniversity of Turin · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inorganic materials are receiving significant interest in medicine given their usefulness for therapeutic applications such as targeted drug delivery, active pharmaceutical carriers and medical imaging. However, poor knowledge of the side effects related to their use is an obstacle to clinical translation. For the development of molecular drugs, the concept of safe-by-design has become an efficient pharmaceutical strategy with the aim of reducing costs, which can also accelerate the translation into the market. In the case of materials, the application these approaches is hampered by poor knowledge of how the physical and chemical properties of the material trigger the biological response. Hemocompatibility is a crucial aspect to take into consideration for those materials that are intended for medical applications. The formation of nanoparticle agglomerates can cause severe side effects that may induce occlusion of blood vessels and thrombotic events. Additionally, nanoparticles can interfere with the coagulation cascade causing both pro- and anti-coagulant properties. There is contrasting evidence on how the physicochemical properties of the material modulate these effects. In this work, we developed two sets of tailored carbon and silica nanoparticles with three different diameters in the 100-500 nm range with the purpose of investigating the role of surface curvature and chemistry on platelet aggregation, activation and adhesion. Substantial differences were found in the composition of the protein corona depending on the chemical nature of the nanoparticles, while the surface curvature was found to play a minor role. On the other hand, large carbon nanoparticles (but not small carbon nanoparticles or silica nanoparticles) have a clear tendency to form aggregates both in plasma and blood. This effect was observed both in the presence or absence of platelets and was independent of platelet activation. Overall, the results presented herein suggest the existence of independent modes of action that are differently affected by the physicochemical properties of the materials, potentially leading to vessel occlusion and/or formation of thrombi in vivo.

Indexed as

aggregationnanoparticlesplatelet aggregationsizesurface chemistry

Identifiers

PMID32280579
PMCPMC7136551
OpenAlexW3014369354

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.